SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported) June 11, 2003

                                 MEDIFAST, INC.
             (Exact name of registrant as specified in its charter)

             Delaware                     000-23016                13-3714405
 -------------------------------       ----------------           -------------
  (State or other jurisdiction         (Commission File           (IRS Employer
of incorporation or organization)           Number)                 Ident. No.)

          11445 Cronhill Drive, Owing Mills, Maryland       21117
          -------------------------------------------    ----------
          (Address of principal executive offices)       (Zip Code)

        Registrant's telephone number, including area code (410)-581-8042

- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)




Item 5. Other Events

1) Effective  June 11, 2003,  Medifast,  Inc.'s  wholly-owned  subsidiary  Jason
Enterprises, Inc. ("Company") (AMEX:MED) completed the acquisition of the assets
of Consumer Choice Systems, Inc., a Delaware corporation,  pursuant to the terms
of the agreement.  The Company will obtain all the assets of the Consumer Choice
Systems Inc.,  business that support their retail and international  business to
include the distribution rights in 18,000 retail food and drug stores.

      The terms of the deal are as follows;  Medifast, Inc. issued 76,120 shares
of Medifast,  Inc.  restricted  common stock and 50,000 five-year  warrants at a
purchase price of $10.00 per share.  The transaction will be accounted for as an
asset  purchase  transaction.  The Company is  expecting  to record  limited and
selected  liabilities  that amount to approximately  $1.35 million.  The Company
intends to  transfer  these  assets to the  balance  sheet of its  wholly  owned
subsidiary, Jason Enterprises,  Inc. The assets and liabilities will be recorded
according to standard GAAP accounting principles. Consumer Choice Systems has an
annualized 12-month revenue of approximately 2 million dollars.

2) Mercantile Safe Deposit and Trust Company increased Medifast,  Inc.'s secured
line of credit from $500,000 to $1 million to provide additional working capital
to Medifast, Inc. and its wholly owned subsidiaries.

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                           MEDIFAST, INC.

Dated: June 11, 2003

                                           /s/ Bradley T. MacDonald
                                           ------------------------------------
                                           Bradley T. MacDonald
                                           Chairman and Chief Executive Officer


                                       2



For Immediate Release
Contact: Medifast, Inc. (AMX:MED)
         Casey Seward, Public & Investor Relations Specialist
         410-504-8154
         www.medifast.net

                    Medifast, Inc. Acquires Women's Wellbeing
    Accretive Acquisition Expected to Increase Annual Revenues by $2 million

      OWINGS MILLS, Md., June 12 /PRNewswire-FirstCall/ -- Medifast, Inc. (Amex:
MED) announced today that Jason Enterprises,  Inc., a wholly owned subsidiary of
Medifast,  acquired the assets of Consumer Choice Systems, Inc. (CCS) a Delaware
corporation.  The  purchase  price was 76,120  restricted  shares of  Medifast's
restricted  common  stock  and the  issuance  of  50,000  warrants  to  purchase
Medifast's common stock at $10.00 per share. Medifast also assumed $1.35 million
in CCS's liabilities. The acquisition is expected to be immediately accretive.

CCS  assembles and  distributes  its products to over 18,000 chain food and drug
stores across the United States.  Its Women's Wellbeing  products focus on women
in  the  age  group  of 14  to  84,  encompassing  multiple  product  categories
including:  1) Urinary Tract Infection products that address detection,  relief,
and prevention and 2) Menopause  Relief products that address night sweats,  hot
flashes  and vaginal  dryness.  Additionally,  Jason  Enterprises  will  develop
cutting edge disease and condition management supplements and skin care products
under the  Women's  Wellbeing  trademark.  The  newly  acquired  company  has an
annualized 12-month revenue of approximately $2 million.

"We believe that the synergies  between the two companies are compelling,"  says
Bradley  MacDonald,  CEO and Chairman of  Medifast.  "CCS has always been on the
leading edge of the women's  health  industry  with advances in new products and
technologies developed to assist mature women under the Women's Wellbeing brand.
We believe  we can  become a leader in this  category  by  combining  our highly
successful  marketing  programs and  distribution  with their promising  product
lines.  The  acquisition  of CCS  demonstrates  our  commitment to expanding our
business model to include an array of nutritional and health care products.  The
Company  will  now be able to  leverage  its  health  network,  advertising  and
distribution  programs to further enhance shareholder value. We are very excited
about this opportunity."

"We are excited about this  opportunity to join the Medifast team which produces
the finest quality medical meal  replacement  products in the disease and weight
management  industry,"  said  Terry  Kelley,  the  president  of  CCS.  "Women's
Wellbeing  and UTI branded  products  are a perfect  complement  to the Medifast
distribution system working with over 15,000 physicians across the country."

Additionally,  in order to  capitalize  this new  opportunity,  Mercantile  Safe
Deposit  and Trust  increased  Medifast,  Inc.'s  secured  line of  credit  from
$500,000 to $1,000,000.



This release contains forward-looking  statements,  which may involve known, and
unknown risks,  uncertainties and other factors that may cause Medifast's actual
results and  performance in future  periods to be materially  different from any
future results or performance  suggested by these statements.  Medifast cautions
investors not to place undue reliance on forward-looking statements, which speak
only to management's expectation on this date.